Relationship Between GLP-1-Based Therapies and Periodontal Health: A Systematic Review of Current Evidence and Future Perspectives.

GLP-1 receptor agonists showed promise in reducing periodontal inflammation and bone loss in laboratory and animal studies, but evidence remains largely preclinical with calls for human clinical trials to establish their clinical value for periodontitis treatment.

A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.